Answers to Key Questions About Antibody–Drug Conjugates in NSCLC

Answers to Key Questions About Antibody–Drug Conjugates in NSCLC Chair and Presenter, Benjamin Levy, MD, Melissa L. Johnson, MD, Stephen V. Liu, MD, and Christine M. Lovly, MD, PhD, discuss NSCLC in this CME/MOC activity titled “Peer Pressure: How Well Do You Know Your ADCs? Answers to Key Questions About Antibody–Drug Conjugates in NSCLC.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/PJD865. CME/MOC credit will be available until March 23, 2024.

Antibody–Drug Conjugates for Solid Tumors: Progress, Possibilities, and Implications for Care
▶︎

Antibody–Drug Conjugates for Solid Tumors: Progress, Possibilities, and Implications for Care

Innovation Takes the Stage in HNSCC
▶︎

Innovation Takes the Stage in HNSCC

Safety Considerations for the Development of Antibody Drug Conjugates
▶︎

Safety Considerations for the Development of Antibody Drug Conjugates

How Dopamine & Serotonin Shape Decisions, Motivation & Learning | Dr. Read Montague
▶︎

How Dopamine & Serotonin Shape Decisions, Motivation & Learning | Dr. Read Montague

Rocky Mountain IBD- March 14- Saturday Morning Recording
▶︎

Rocky Mountain IBD- March 14- Saturday Morning Recording

Innovations in Pediatric HCM Care: The SCOUT-HCM Clinical Trial of Mavacamten
▶︎

Innovations in Pediatric HCM Care: The SCOUT-HCM Clinical Trial of Mavacamten

SABCS 2024: People's choice - future directions in antibody drug conjugates
▶︎

SABCS 2024: People's choice - future directions in antibody drug conjugates

Clinical Pearls for Subcutaneous Delivery: Optimizing Anti-CD38 Delivery in Multiple Myeloma
▶︎

Clinical Pearls for Subcutaneous Delivery: Optimizing Anti-CD38 Delivery in Multiple Myeloma

Improve Energy & Longevity by Optimizing Mitochondria | Dr. Martin Picard
▶︎

Improve Energy & Longevity by Optimizing Mitochondria | Dr. Martin Picard

SABCS 2023: Toxicity Management - Next Gen Therapies Means Next Gen Toxicities
▶︎

SABCS 2023: Toxicity Management - Next Gen Therapies Means Next Gen Toxicities

The Promise of Oral Therapy for HER2-Mutated NSCLC: Unlocking NewTreatment Opportunities
▶︎

The Promise of Oral Therapy for HER2-Mutated NSCLC: Unlocking NewTreatment Opportunities

Medical breakthroughs and health stories | 60 Minutes Marathon
▶︎

Medical breakthroughs and health stories | 60 Minutes Marathon

TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal
▶︎

TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal

#3 2025 08 23 Cancer Center Lynch Syndrome Symposium   Preventing Cancers in Lynch Syndrome
▶︎

#3 2025 08 23 Cancer Center Lynch Syndrome Symposium Preventing Cancers in Lynch Syndrome

The Complete Cardiology Masterclass: Exam-Ready in One Video
▶︎

The Complete Cardiology Masterclass: Exam-Ready in One Video

Lung Cancer Breakout: Breakthrough treatments for longer life
▶︎

Lung Cancer Breakout: Breakthrough treatments for longer life

CAOH 2025: Ana C Garrido Castro, MD - Assistant Professor of Medicine, Dana Farber Cancer Institute
▶︎

CAOH 2025: Ana C Garrido Castro, MD - Assistant Professor of Medicine, Dana Farber Cancer Institute

Baim Grand Rounds Katherine Tuttle 15Jun2026
▶︎

Baim Grand Rounds Katherine Tuttle 15Jun2026

New Strategies to Improve Outcomes of Non-HPV-Associated Recurrent/Metastatic Head and Neck Cancer
▶︎

New Strategies to Improve Outcomes of Non-HPV-Associated Recurrent/Metastatic Head and Neck Cancer

Targeting With Precision in Advanced Ovarian Cancer
▶︎

Targeting With Precision in Advanced Ovarian Cancer